Real-world efficacy, safety and clinical outcomes of ombitasvir/ paritaprevir/ ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: Turkey experience
Keyword(s):
2020 ◽
Vol 31
(4)
◽
pp. 305-317
◽
Keyword(s):
Keyword(s):
2020 ◽
Vol 35
(7)
◽
pp. 1238-1246
◽
2018 ◽
Vol 53
(10)
◽
pp. 1142-1150
◽
Keyword(s):
Keyword(s):
2019 ◽
Vol 34
(4)
◽
pp. 794-801
◽
Keyword(s):
2018 ◽
Vol 53
(12)
◽
pp. 1276-1284
◽